Live Breaking News & Updates on Applying evidence

Stay informed with the latest breaking news from Applying evidence on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Applying evidence and stay connected to the pulse of your community

Closing Thoughts on Advanced HCC and Highlights from ASCO GI 2023

Closing out this discussion, experts share their final thoughts on advanced HCC treatments and key data presented at the 2023 ASCO Gastrointestinal Cancers Symposium.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection , Locoregional , Tace

Systemic Immunotherapies for Advanced HCC in Second Line and Beyond

In the context of frontline treatment strategies in advanced HCC, expert oncologists review clinical research in systemic immunotherapy approaches.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Second-line , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection , Locoregional

Anti-Angiogenic Systemic Therapies for Advanced HCC in Second Line and Beyond

Expert panelists highlight anti-angiogenic systemic therapies under investigation for advanced HCC in second line and beyond.

Transforming-outcomes , Hepatocellular-carcinoma , Expert-insights , Applying-evidence , Angiogenic-systemic-therapies , Second-line , Hcc , Intermediate-stage , Systemic-therapy , Bclc-stage-b , Patient-selection

Actinium Pharmaceuticals, Inc. to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering...

Florida , United-states , Salt-lake-city , Utah , Salt-palace-convention-center , Canada , Texas , American , Hans-vitzthum , Boglarka-gyurkocza , Sandesh-seth , James-foran